Intragenic Cis and Trans Modification of Genetic Susceptibility in DYT1 Torsion Dystonia
Overview
Affiliations
A GAG deletion in the DYT1 gene is a major cause of early-onset dystonia, but clinical disease expression occurs in only 30% of mutation carriers. To gain insight into genetic factors that may influence penetrance, we evaluated three DYT1 single-nucleotide polymorphisms, including D216H, a coding-sequence variation that moderates the effects of the DYT1 GAG deletion in cellular models. We tested DYT1 GAG-deletion carriers with (n=119) and without (n=113) clinical signs of dystonia and control individuals (n=197) and found the frequency of the 216H allele to be increased in GAG-deletion carriers without dystonia and to be decreased in carriers with dystonia, compared with the control individuals. Analysis of haplotypes demonstrated a highly protective effect of the H allele in trans with the GAG deletion; there was also suggestive evidence that the D216 allele in cis is required for the disease to be penetrant. Our findings establish, for the first time, a clinically relevant gene modifier of DYT1.
Blair D, Risch N medRxiv. 2024; .
PMID: 39399029 PMC: 11469360. DOI: 10.1101/2024.09.23.24314008.
Clinical relevance and translational impact of reduced penetrance in genetic movement disorders.
Heinzel S, Mascalzoni D, Baumer T, Berg D, Kasten M, Bruggemann N Med Genet. 2024; 34(2):151-156.
PMID: 38835915 PMC: 11006340. DOI: 10.1515/medgen-2022-2128.
Seibler P, Rakovic A Med Genet. 2024; 34(2):125-130.
PMID: 38835901 PMC: 11006347. DOI: 10.1515/medgen-2022-2133.
Motor deficit and lack of overt dystonia in Dlx conditional Dyt1 knockout mice.
Berryman D, Barrett J, Liu C, Maugee C, Waldbaum J, Yi D Behav Brain Res. 2022; 439:114221.
PMID: 36417958 PMC: 10364669. DOI: 10.1016/j.bbr.2022.114221.
Dystonia Diagnosis: Clinical Neurophysiology and Genetics.
di Biase L, Di Santo A, Caminiti M, Pecoraro P, Carbone S, Di Lazzaro V J Clin Med. 2022; 11(14).
PMID: 35887948 PMC: 9320296. DOI: 10.3390/jcm11144184.